RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus.

This research article suggests that using RNA interference (RNAi) might be a potentially effective method to protect horse cells from the Equine Arteritis Virus (EAV) in a lab environment.

Research Methodology and Experimentation

• The objective of this study was to test the efficacy of RNA interference (RNAi) as a possible defense against Equine Arteritis Virus (EAV) in a lab setting. This could be an exciting step in creating new treatments against the infection.
• For the experiment, horse cells were exposed to small interfering RNA oligonucleotides (siRNAs). These molecules are known to interfere with the expression of certain genes in a process called RNAi.
• After applying the siRNAs, the researchers infected the cells with EAV and monitored the results. They report that use of siRNAs led to notable protection of the cells, with virus titers drastically decreasing.

Key Findings

• The siRNAs derived from DNA plasmids which expressed small hairpin RNAs (shRNAs) were also found to be effective.
• The siRNAs that targeted the open reading frame 1 (coding for non-structural proteins) produced the most pronounced protective effect. However, those siRNAs targeting sequences for several structural proteins had less or no effect.
• In terms of timing, the findings showed that applying siRNAs shortly after the virus was introduced led to significant survival rates of cells. By contrast, transfection at later time points resulted in fewer benefits for the cells.

Study Implications and Prospects

• The outcomes of this study suggest that RNAi could hold potential as a therapeutic approach against EAV.
• Specifically, siRNAs targeting non-structural proteins may offer the most potent defense against EAV.
• The research also sheds light on the important role that timing plays in the successful application of RNAi. This could be very important when developing RNAi-based treatments against EAV in future studies.